步长制药跌2.03%，成交额1.01亿元，主力资金净流出731.79万元

Company Overview - Shandong Buchang Pharmaceutical Co., Ltd. is located in Mudan District, Heze City, Shandong Province, established on May 10, 2001, and listed on November 18, 2016. The company specializes in the research, production, and sales of traditional Chinese medicine [1][2]. Stock Performance - As of August 22, Buchang Pharmaceutical's stock price decreased by 2.03%, trading at 18.78 CNY per share, with a total market capitalization of 19.805 billion CNY. The stock has increased by 18.86% year-to-date, with a 1.95% rise over the last five trading days, 4.04% over the last twenty days, and 13.68% over the last sixty days [1]. Financial Performance - For the period from January to March 2025, Buchang Pharmaceutical reported a revenue of 2.785 billion CNY, reflecting a year-on-year growth of 5.47%. The company has cumulatively distributed 7.537 billion CNY in dividends since its A-share listing, with 1.197 billion CNY distributed over the last three years [2]. Shareholder Information - As of March 31, 2025, the number of shareholders for Buchang Pharmaceutical was 59,500, a decrease of 0.44% from the previous period. The average number of circulating shares per shareholder increased by 0.44% to 18,587 shares [2]. Institutional Holdings - Among the top ten circulating shareholders as of March 31, 2025, Hong Kong Central Clearing Limited ranked as the ninth largest shareholder, holding 7.8596 million shares, a decrease of 576,000 shares from the previous period [2].